Liwei Guo

957 total citations · 1 hit paper
21 papers, 603 citations indexed

About

Liwei Guo is a scholar working on Molecular Biology, Cell Biology and Surgery. According to data from OpenAlex, Liwei Guo has authored 21 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Surgery. Recurrent topics in Liwei Guo's work include Cholesterol and Lipid Metabolism (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related molecular mechanisms research (3 papers). Liwei Guo is often cited by papers focused on Cholesterol and Lipid Metabolism (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related molecular mechanisms research (3 papers). Liwei Guo collaborates with scholars based in China, United States and Switzerland. Liwei Guo's co-authors include Jinrong Peng, Zhipeng Ma, Peipei Zhu, Shuming Chen, Zhe Zhang, Qing‐He Zhang, Hui Shi, Jun Chen, Yanan Chen and Lei Zheng and has published in prestigious journals such as Nature, Nature Biotechnology and Scientific Reports.

In The Last Decade

Liwei Guo

20 papers receiving 600 citations

Hit Papers

PTC-bearing mRNA elicits a genetic compensation response ... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liwei Guo China 12 401 100 87 84 59 21 603
Charles DeRossi United States 12 507 1.3× 103 1.0× 86 1.0× 130 1.5× 36 0.6× 14 730
Shinya Ohata Japan 14 441 1.1× 172 1.7× 37 0.4× 207 2.5× 56 0.9× 37 789
Е. А. Алексеева United States 10 585 1.5× 103 1.0× 36 0.4× 108 1.3× 44 0.7× 28 904
Yoon Ha Choi South Korea 17 466 1.2× 88 0.9× 69 0.8× 96 1.1× 78 1.3× 29 780
Tatiana Subkhankulova United Kingdom 11 474 1.2× 72 0.7× 96 1.1× 87 1.0× 19 0.3× 15 597
Yuji Funakoshi Japan 18 786 2.0× 74 0.7× 81 0.9× 211 2.5× 31 0.5× 32 1.0k
Shouyuan Zhao China 18 593 1.5× 62 0.6× 90 1.0× 84 1.0× 22 0.4× 46 782
Alex Chen United States 12 539 1.3× 106 1.1× 63 0.7× 37 0.4× 33 0.6× 24 702
Brian E. McIntosh United States 13 561 1.4× 117 1.2× 79 0.9× 51 0.6× 23 0.4× 20 971
Yixing Zhou United States 13 359 0.9× 29 0.3× 26 0.3× 90 1.1× 83 1.4× 22 655

Countries citing papers authored by Liwei Guo

Since Specialization
Citations

This map shows the geographic impact of Liwei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Guo more than expected).

Fields of papers citing papers by Liwei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Guo. The network helps show where Liwei Guo may publish in the future.

Co-authorship network of co-authors of Liwei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Guo. A scholar is included among the top collaborators of Liwei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Guo. Liwei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Liwei, et al.. (2025). GALNT4 controls aortic dissection by regulating vascular smooth muscle cell phenotype switch and dysfunction through the TGF-β/smad signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(7). 167969–167969.
2.
Li, Haijian, Xiaolin Sun, Wenqiang Cui, et al.. (2024). Computational drug development for membrane protein targets. Nature Biotechnology. 42(2). 229–242. 27 indexed citations
3.
Guo, Liwei, et al.. (2024). Emerging Roles of UDP-GalNAc Polypeptide N-Acetylgalactosaminyltransferases in Cardiovascular Disease. Aging and Disease. 2 indexed citations
4.
Wang, Zixu, Liwei Guo, Ce Gao, et al.. (2023). Wdr5-mediated H3K4me3 coordinately regulates cell differentiation, proliferation termination, and survival in digestive organogenesis. Cell Death Discovery. 9(1). 227–227. 6 indexed citations
5.
Guo, Liwei, et al.. (2022). Elevated Fibroblast Growth Factor 23 Impairs Endothelial Function through the NF-κB Signaling Pathway. Journal of Atherosclerosis and Thrombosis. 30(2). 138–149. 9 indexed citations
6.
Piao, Lianhua, Liwei Guo, Luhui Wang, et al.. (2022). Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK-Src-Ras-ERK1/2 signaling pathway. Cancer Cell International. 22(1). 183–183. 17 indexed citations
7.
Piao, Lianhua, Liwei Guo, Jiawen Wang, et al.. (2022). Tspan9 Induces EMT and Promotes Osteosarcoma Metastasis via Activating FAK-Ras-ERK1/2 Pathway. Frontiers in Oncology. 12. 774988–774988. 12 indexed citations
8.
Zhao, Ting, Liwei Guo, Zhipeng Ma, et al.. (2021). Loss-of-function of p53 isoform Δ113p53 accelerates brain aging in zebrafish. Cell Death and Disease. 12(2). 151–151. 15 indexed citations
9.
Zhao, An, Liwei Guo, Ji Xu, et al.. (2019). Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer. Cancer Medicine. 8(7). 3566–3574. 21 indexed citations
10.
Ma, Zhipeng, Peipei Zhu, Hui Shi, et al.. (2019). PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components. Nature. 568(7751). 259–263. 312 indexed citations breakdown →
11.
Zhou, Huanhuan, et al.. (2018). Prognostic significance of mammary Paget’s disease in Chinese women: a 10 year, population-based, matched cohort study. OncoTargets and Therapy. Volume 11. 8319–8326. 12 indexed citations
12.
Zheng, Lei, Huanhuan Zhou, Liwei Guo, et al.. (2018). Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway. OncoTargets and Therapy. Volume 11. 1941–1948. 13 indexed citations
13.
Duan, Li, et al.. (2018). Long non‑coding RNA HR1 participates in the expression of SREBP‑1c through phosphorylation of the PDK1/AKT/FoxO1 pathway. Molecular Medicine Reports. 18(3). 2850–2856. 27 indexed citations
14.
Zhou, Huanhuan, Lei Zheng, Yun Gao, et al.. (2017). Downregulation of Cohesin Loading Factor Nipped-B-Like Protein (NIPBL) Induces Cell Cycle Arrest, Apoptosis, and Autophagy of Breast Cancer Cell Lines. Medical Science Monitor. 23. 4817–4825. 17 indexed citations
15.
Ma, Zhipeng, Peipei Zhu, Liwei Guo, et al.. (2017). A novel inducible mutagenesis screen enables to isolate and clone both embryonic and adult zebrafish mutants. Scientific Reports. 7(1). 10381–10381. 9 indexed citations
17.
Sun, Duoli, Zhenghong Peng, David S. Maxwell, et al.. (2013). Improved synthesis of 17β-hydroxy-16α-iodo-wortmannin, 17β-hydroxy-16α-iodoPX866, and the [131I] analogue as useful PET tracers for PI3-kinase. Bioorganic & Medicinal Chemistry. 21(17). 5182–5187. 4 indexed citations
18.
Wang, Kejie, et al.. (2010). [The relationship between GAPDH mRNA degradation in the mouse liver and postmortem interval].. PubMed. 26(6). 425–7. 7 indexed citations
19.
Marcos, Josep, Liwei Guo, William K. Wilson, Forbes D. Porter, & Cedric Shackleton. (2003). The implications of 7-dehydrosterol-7-reductase deficiency (Smith–Lemli–Opitz syndrome) to neurosteroid production. Steroids. 69(1). 51–60. 43 indexed citations
20.
Guo, Liwei, Cedric Shackleton, & William K. Wilson. (2001). Synthesis of Ring B Unsaturated Estriols. Confirming the Structure of a Diagnostic Analyte for Smith−Lemli−Opitz Syndrome. Organic Letters. 3(16). 2547–2550. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026